Showing results (61-70 of 447) with videos related to
Sort By:
Pageof 45
Japanese Journal of Clinical Oncology|September 3, 2024
Real-world safety of nivolumab in patients with malignant pleural mesothelioma in Japan: post-marketing surveillance studyNobukazu Fujimoto, Ayumi Akamatsu, Chikara Honda, et al.Thoracic Cancer|March 22, 2022
Rapidly progressing metastatic malignant melanoma mimicking primary pleural tumor: A case reportClara So, Tatsuya Yoshida, Takaaki Mizuno, et al.Thoracic Cancer|December 1, 2022
Co-occurring KEAP1 and TP53 mutations in lung squamous cell carcinoma induced primary resistance to thoracic radiotherapy: A case reportRumi Nishimura, Tatsuya Yoshida, Masahiro Torasawa, et al.Gan to Kagaku Ryoho. Cancer & Chemotherapy|January 22, 2024
[History of the Japanese Society of Medical Oncology]Chikashi Ishioka, Hironobu Minami, Yuichiro Ohe, et al.Japanese Journal of Clinical Oncology|August 17, 2022
Medical management of older patients with lung cancerYoshitaka Zenke, Taiki Hakozaki, Yoshiro Nakahara, et al.The Clinical Respiratory Journal|June 16, 2015
Diagnostic utility of endobronchial ultrasound with a guide sheath under the computed tomography workstation (ziostation) for small peripheral pulmonary lesionsYuji Matsumoto, Takehiro Izumo, Shinji Sasada, et al.Clinical Lung Cancer|March 16, 2021
Activity and Immune Correlates of Programmed Death-1 Blockade Therapy in Patients With Advanced Large Cell Neuroendocrine CarcinomaMasayuki Shirasawa, Tatsuya Yoshida, Daisuke Takayanagi, et al.Thoracic Cancer|May 20, 2024
Response to dabrafenib plus trametinib on a rare BRAF mutation (V600_W604 deletion-insertion R) in an advanced non-small cell lung cancer patientAkiko Tamura, Ryoko Inaba Higashiyama, Tatsuya Yoshida, et al.Thoracic Cancer|August 24, 2023
Exploratory analysis to predict pneumonitis during durvalumab consolidation therapy for patients with locally advanced non-small cell lung cancer from proteomic profiling of circulating extracellular vesiclesMasahiro Torasawa, Hidehito Horinouchi, Shigehiro Yagishita, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 22, 2021
Differential Immune-Related Microenvironment Determines Programmed Cell Death Protein-1/Programmed Death-Ligand 1 Blockade Efficacy in Patients With Advanced NSCLCMasayuki Shirasawa, Tatsuya Yoshida, Yukiko Shimoda, et al.Pageof 45